Bio-Rad Laboratories SG&A Expenses 2010-2025 | BIO

Bio-Rad Laboratories sg&a expenses for the twelve months ending March 31, 2025 were $0.808B, a 2.79% decline year-over-year.

  • Bio-Rad Laboratories annual sg&a expenses for 2024 were $0.814B, a 3.29% decline from 2023.
  • Bio-Rad Laboratories annual sg&a expenses for 2023 were $0.842B, a 1.68% increase from 2022.
  • Bio-Rad Laboratories annual sg&a expenses for 2022 were $0.828B, a 5.62% decline from 2021.

Bio-Rad Laboratories SG&A Expenses 2010-2025 | BIO

  • Bio-Rad Laboratories annual sg&a expenses for 2024 were $0.814B, a 3.29% decline from 2023.
  • Bio-Rad Laboratories annual sg&a expenses for 2023 were $0.842B, a 1.68% increase from 2022.
  • Bio-Rad Laboratories annual sg&a expenses for 2022 were $0.828B, a 5.62% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$219.8B
Boston Scientific (BSX)$156.6B
Stryker (SYK)$152.9B
EssilorLuxottica (ESLOY)$137.9B
Medtronic (MDT)$118B
Lonza Group Ag (LZAGY)$49.3B
Haleon (HLN)$43.6B
ResMed (RMD)$40.1B
GE HealthCare Technologies (GEHC)$35.6B
Agilent Technologies (A)$34B
Terumo (TRUMY)$25.6B
Koninklijke Philips (PHG)$24.7B
Insulet (PODD)$20.6B
Zimmer Biomet Holdings (ZBH)$19B
Baxter (BAX)$14.6B
Smith & Nephew SNATS (SNN)$13.7B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.1B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.8B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.3B